Target intelligence / Profile preview

Herpes simplex virus 1 glycoprotein C (gC)

Target
gC
Molecular classification
Viral envelope glycoprotein, Type I membrane protein, Receptor, Complement-binding protein
01

Overview

Herpes simplex virus 1 glycoprotein C (gC) is a multifunctional type I transmembrane protein located in the viral envelope. It plays a critical role in the initial stages of infection by mediating the attachment of the virus to host cell surface heparan sulfate proteoglycans (1.1.2, 1.4.2). Beyond attachment, gC is a key player in immune evasion; it binds to the C3b component of the host complement system, thereby inhibiting complement-mediated neutralization and lysis of infected cells (1.1.2, 1.4.3). It also acts as a physical shield for other essential glycoproteins like gB and gD, protecting them from neutralizing antibodies (1.4.3, 1.4.5). Because of these roles, gC is a prominent target in the development of vaccines and antiviral therapies aimed at blocking viral entry and enhancing the host's immune response (1.1.1, 1.4.3). Experimental treatments include heparan sulfate mimetics like PI-88 and monoclonal antibodies that disrupt its binding capabilities (1.2.1, 1.4.4).

Other names
gCgC1UL44Envelope glycoprotein CHuman herpesvirus 1 glycoprotein C
02

Mechanism of action

Inhibition of viral attachment to heparan sulfate proteoglycans and blockade of complement-mediated immune evasion.

03

Biological functions

Viral attachmentImmune evasionViral entryCell-to-cell spread
04

Disease associations

InfectionHerpes simplexKeratitisEncephalitis
05

Safety considerations

Immune evasionAntigenic variationIncomplete neutralization
06

Interacting drugs

PI-88

2 more in the full profile.

07

Biomarkers

Anti-gC antibodiesViral gC DNA/RNA

Beyond the preview

Go deeper on Herpes simplex virus 1 glycoprotein C (gC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Herpes simplex virus 1 glycoprotein C (gC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call